Tablets 1mg, 5mg
e/c tablets 2.5mg

First line oral corticosteroid treatment.

25mg tablets are classified as Do Not Prescribe.

There is no evidence that e/c prednisolone reduces the risk of gastrointestinal side effects. Uncoated 5mg tablets should be prescribed first line together with a PPI if necessary.

Foam 20mg/metered application,
Retention enema 20mg/100mL,
Suppositories 5mg

Prednisolone rectal preparations are reserved for patients who do not respond to budesonide rectal.

e/c capsules 3mg
e/c granules 9mg/sachet
Foam enema

First line rectal treatment (foam enema)

Capsules 3mg, Enema

Modified release capsules 4mg (targeted release)

For treating primary IgA nephropathy in accordance with NICE TA937

Tablets, M/R 9 mg